Don't want to miss the best from Business Standard?
Sales rise 31.30% to Rs 91.08 crore
Net Loss of Astec Lifesciences reported to Rs 33.04 crore in the quarter ended June 2025 as against net loss of Rs 39.72 crore during the previous quarter ended June 2024. Sales rose 31.30% to Rs 91.08 crore in the quarter ended June 2025 as against Rs 69.37 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales91.0869.37 31 OPM %-12.07-66.67 -PBDT-21.52-52.37 59 PBT-33.02-61.64 46 NP-33.04-39.72 17Powered by Capital Market - Live News
Make smarter market moves with The Smart Investor. Daily insights on buzzing stocks and actionable information to guide your investment decisions delivered to your inbox.
Disclaimer: No Business Standard Journalist was involved in creation of this content
